Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
about
Fluid-phase pinocytosis of native low density lipoprotein promotes murine M-CSF differentiated macrophage foam cell formationMonocytes in atherosclerosis: subsets and functionsHorror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosisCD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimerAbsence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/IICD36: implications in cardiovascular diseaseMacrophage-mediated cholesterol handling in atherosclerosisScavenger Receptors: Emerging Roles in Cancer Biology and ImmunologyOxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosisGenetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred StrainsTumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytesMacrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosisRegulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion developmentThe innate immune response to products of phospholipid peroxidationGeneration and biological activities of oxidized phospholipidsApolipoprotein E-deficient lipoproteins induce foam cell formation by downregulation of lysosomal hydrolases in macrophagesOX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularizationCD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammationABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of ceramide linoleic estersCD36 inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosisNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsMacrophages in the pathogenesis of atherosclerosisNovel functions of PXR in cardiometabolic disease.Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis.Mechanisms by which diabetes increases cardiovascular disease.Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice.The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress.Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarctionCD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury.Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.Mechanisms that regulate macrophage burden in atherosclerosis.CD36, a scavenger receptor implicated in atherosclerosis.Oxidized LDL: diversity, patterns of recognition, and pathophysiology.You are right too!Cholesterol selectively activates canonical Wnt signalling over non-canonical Wnt signalling.Minimally oxidized LDL inhibits macrophage selective cholesteryl ester uptake and native LDL-induced foam cell formation.
P2860
Q21558503-D4856D8D-AECA-4A97-8CE8-4EA7E327E752Q22251045-ED22769E-CE52-416C-8E32-3BBE779060B5Q24631660-4A424526-1821-46AE-80F6-93DC49D90A3FQ24634165-D30A2CF0-A184-4B6B-A3DD-3C002139B278Q24642646-AE08FC36-EAF4-48BE-A54F-925BD591D6A9Q24658096-3A33E9DC-C6DF-42A6-85E6-C3C161E65E65Q24678338-56B56040-BA54-42D3-B15E-48D235FFC89BQ26780405-1A3ACA06-5178-43B4-9F89-1E3E30BECF46Q26799114-C941C1DD-F809-45B8-A649-AD09DD97DD68Q26822962-1F603485-6B6F-46AB-A2B8-61DEBD7AB8AAQ27309881-F120BAE6-18F0-4342-86C5-96B3B2300344Q28219857-0FAEFE62-0257-4B43-B39C-4894F41A047BQ28255651-97E73B4D-9EFC-4BD3-9DDE-843E90F153A0Q28260242-58538664-06CA-4132-B6B0-BB12491F1BDBQ28389385-512C4889-C1E0-4F77-B3BF-8F9281E5C6A2Q28389691-E810F211-2018-430D-B9C4-10FE3D993F43Q28506019-C295EE1E-A9D3-4F15-ADDB-F98B26C8F4C6Q28506359-15829114-C7F3-435E-8A29-ED6013AECEABQ28506984-E9F43B08-C457-42FE-8035-F6E83A845F7CQ28511467-BE833136-A194-4F84-816F-C6C1DC9F4C6FQ28729175-B639C0E4-35DE-4F86-AAAA-89141AA17D5FQ29615704-9145A980-8DA0-4E66-BE72-309B3623D5E0Q29617765-2F70F035-D8AD-4BD3-9A86-31289BB96680Q30251861-9742E524-9EEF-4BD0-9513-05CCA4BDC794Q30436299-C4400D65-DEA9-42FE-A1A4-B0327AF43CF2Q30441275-99849A16-9633-44E8-9F75-F6661F5605C2Q30559538-6094EE42-D721-452D-8851-0C1BAFBA1474Q33547771-C8ECF77F-4DF5-49E5-ACC2-D52181AD1E6CQ33552642-DAC34D9F-7A0C-454E-87A0-4C2E1C94DA32Q33609100-EC613FBE-0623-479A-8663-499F500A0CEEQ33641499-DA6A89FC-7743-45D9-BEDA-D835BA48CE2BQ33653519-7CC5D174-B1E5-40B8-9897-37A13B51F591Q33697097-87E9B7A8-54EB-42F0-9E3F-37C7B85BD98FQ33752256-E212DFE2-3899-48A8-A0DE-9E51EA579B9BQ33761114-5CC1B695-C57D-42CA-A2CC-95FB4A4F20C1Q33844864-5E4E74B6-C166-4C50-82D3-612B9CA9F45BQ33879138-B3C1D5DC-E467-4E73-AFD0-BB5912EEA4E1Q33905863-189B97D1-9EE0-4001-ABA5-1F8523E504F8Q33908017-F6ADD6BA-E4DD-4E3A-857E-C3319821678FQ33945076-064AC08B-F036-44D7-840F-E8D5144D7590
P2860
Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Loss of receptor-mediated lipi ...... lerosis in hyperlipidemic mice
@ast
Loss of receptor-mediated lipi ...... lerosis in hyperlipidemic mice
@en
type
label
Loss of receptor-mediated lipi ...... lerosis in hyperlipidemic mice
@ast
Loss of receptor-mediated lipi ...... lerosis in hyperlipidemic mice
@en
prefLabel
Loss of receptor-mediated lipi ...... lerosis in hyperlipidemic mice
@ast
Loss of receptor-mediated lipi ...... lerosis in hyperlipidemic mice
@en
P2093
P2860
P356
P1476
Loss of receptor-mediated lipi ...... lerosis in hyperlipidemic mice
@en
P2093
Anita A Tseng
Jennifer J Manning
Jessica M Silver
Kathryn J Moore
Mary McKee
Mason W Freeman
Stephanie L Koehn
Vidya V Kunjathoor
P2860
P304
P356
10.1172/JCI24061
P407
P577
2005-08-01T00:00:00Z